1Ventura p,pariai R,Veriato C,etal Peroxidation in dices and to talanfioxidation capacity in plasna duiring hyperhomocysteinem ia byoral bading[J].Metabolisn,2000,49:225.
2Fischer PA,Domiguez GN,cuniben LA,etal hyperhomocyst eineinduces renal hemodynam ic dysfunction:Is nitric oxlde involved[J].J Am Soc Nephrol,2003,14:653.
2Ueland P M,Refsum H,Stabler SP,et al.Total homocysteine in plasma of serum:Methods and clinical applications[J].Clin Chem,1993,39(9):1764~1769.
3Jacobsen D W,Gatautis V J,Green R,et al.Rapid HPLC determination of total homocysteine and other thiol in serum and plasma:sex differences and correlation with cobalamin and folate concentrations in healthy subjects[J].Clin Chem,1994,40(5):873~882.
4Malinow M R.Plasma homocyst(e)ine and arterial occusine disease:A mini-review.Clim Chem,1995,41(1):173~176.
5Mayer E L,Jacobsen D W,Robinson K,et al.Homocysteine and coronary atherosclerosis.JAM Coll Cardiol,1969,23(3):517~527.
6Boushey C J, Beresford S A, Omenn G S, et al.A quantitative assessment of Plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.J Am Med Assoc.1995:274:1049~1057.
8Arnesen E,Refsum H,Bonaa K H,et al.Serum total homocysteine and coronary heart disease.Int J Epidemiol,1995,24(4):704~709.
9Stampfer M J,Malinow M R.Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med,1995,332(5):328~329.
10Dalery K,Lussier C S,Selhub J,et al.Homocysteine and coronary artery disease in franch canakian subject:relation with vitamins B12,B6,pyridoxal phosphate and folate.Am J Cardiol,1995,75:1107~1111.
2Mosley WJ, Greenland P, Garside DB, et al. Predictive ufiHty of pulse pressure and other blood pressure meas- ures for cardiovascular outcomes [J]. Hypertension, 2007,49 (6) .- 1256-1264.
3Rutan G. Mortality associated with diastolic hypertension and isola- ted systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial[J]. Circulation,2008,77(22) :504.